Aurovela 1/20 Tablet
Product Images NDC 65862-939

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aurovela 1/20 (NDC 65862-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

FDA Label Image

Blister Pack (Norethindroneethinyl Fig2)

FDA Label Image

Blister Pack (Norethindroneethinyl Fig3)

Blister Pack (Norethindroneethinyl Fig3)
This is a set of instructions or guidelines for starting birth control pills. It mentions "Sunday starters" and "Day-1 starters", indicating two different methods for starting the pills depending on whether the person's period begins on a Sunday or a different day. There is also a label sticker for the day of the period start. The name of a birth control pill, Aurovela™ 1720, is also mentioned.*
FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)
The text provides instructions for women who start their period on a day other than Sunday to place a label sticker indicating the first day of their period. It also mentions a medication called Aurovela 1720 that contains Norethindrone Aceate and Estradiol Tablets. No other information is available.*
FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton)

FDA Label Image

Norethindroneethinyl Fig6

Norethindroneethinyl Fig6
This is a package of Urovela™ 1/20, containing 5 blister packs and each blister pack contains 21 light yellow to yellow tablets for a 21-day regimen. Each tablet contains 1 mg Norethindrone acetate USP and 20 meg Ethinyl Estradiol USP. The product is intended to prevent pregnancy and does not protect against HIV infection and other sexually transmitted diseases. The recommended usage is one tablet daily for 21 days as directed by the physician. It is important to keep the package out of reach of children and store at 20° to 25°C. It includes a detailed patient labeling, brief summary, patient package insert, and day label. It is distributed by Aurobindo Pharma USA, Inc. and made in India.*
FDA Label Image

Chemical Structure1 (Norethindroneethinyl Str1)

FDA Label Image

Chemical Structure2 (Norethindroneethinyl Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.